Occupational exposure to chemotherapy of pharmacy personnel at a single centre.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The Canadian Journal of Hospital Pharmacy

• Publication date

  2015-04-28

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.4212/CJHP.V68I2.1435PMID 25964681PMCID PMC4414071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning

  2012cited by this paper
• Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan

  2011cited by this paper
• Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device

  2011cited by this paper
• Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan

  2011cited by this paper
• Evaluation of Antineoplastic Drug Exposure of Health Care Workers at Three University-Based US Cancer Centers

  2010cited by this paper
• Evaluation of surface contamination in a hospital hematology—oncology pharmacy

  2009cited by this paper
• Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device

  2007cited by this paper
• A pooled analysis to study trends in exposure to antineoplastic drugs among nurses.

  2007cited by this paper
• Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.

  2007cited by this paper
• Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs

  2006cited by this paper
• Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.

  2006cited by this paper
• Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities

  2005cited by this paper
• Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees.

  2005cited by this paper
• Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study.

  2004cited by this paper
• Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations

  2003cited by this paper
• Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.

  2003cited by this paper
• Occupational exposure to cytotoxic drugs in two UK oncology wards

  2002cited by this paper
• Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area.

  2002cited by this paper
• Monitoring method for surface contamination caused by selected antineoplastic agents.

  2002cited by this paper
• Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations

  2002cited by this paper
• Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.

  2002cited by this paper
• Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys.

  2000cited by this paper
• Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists.

  1999cited by this paper
• Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.

  1999cited by this paper
• Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics.

  1999cited by this paper
• Biomonitoring Occupational Exposure to Cytostatic Anticancer Drugs

  1997cited by this paper
• Pediatric Dosage Handbook

  1997cited by this paper
• Monitoring of occupational exposure to cytostatic anticancer agents.

  1996cited by this paper
• Monitoring occupational exposure to cancer chemotherapy drugs.

  1996cited by this paper
• Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.

  1994cited by this paper
• Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents.

  1994cited by this paper
• Exposure of hospital pharmacists and nurses to antineoplastic agents.

  1993cited by this paper
• Determination of cyclophosphamide in urine by gas chromatography-mass spectrometry.

  1993cited by this paper
• Occupational exposure to antineoplastic agents at several departments in a hospital

  1992cited by this paper
• Detection of contamination with antineoplastic agents in a hospital pharmacy department

  1992cited by this paper
• The risks of handling cytotoxic drugs

  1990cited by this paper
• Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.

  1985cited by this paper
• A study of occupational exposure to antineoplastic drugs and fetal loss in nurses.

  1985cited by this paper
• Occupational exposure to cyclophosphamide.

  1984cited by this paper
• Mutagenicity in urine of nurses handling cytostatic drugs.

  1979cited by this paper
• Mutagenicity in urine of nurses handling cytostatic drugs.

  1979cited by this paper

• Evaluation of the effect of closed system transfer device syringe adaptor connection in the isolator on cytotoxic residue contamination during intravenous administration.

  2025cites this paper
• Health Effects of Ergonomics and Personal Protective Equipment on Chemotherapy Professionals

  2025cites this paper
• Occupational hazards and population-based prevention strategies for pharmacy workers in Canada

  2024cites this paper
• Hesperidin as a bioactive compound in citrus fruits reduces N-ethyl-N-nitrosourea-induced mortality and toxicity in mice: as a model for chronic lymphocytic leukemia

  2024cites this paper
• Real-world study of the leakage of two types of infusion bags in multicenter pharmacy intravenous admixture service (PIVAS)

  2023cites this paper
• Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data

  2022influential citation
• Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

  2021cites this paper
• Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit

  2021cites this paper
• ABOUT THE POSSIBILITY OF TOXIC EFFECTS DEVELOPING IN CONTACT WITH N-NITROSOALKYLUREA DERIVATIVE - LYSOMUSTINE

  2020cites this paper
• Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study

  2020cites this paper
• Surface contamination of counting tools after mock dispensing of cyclophosphamide in a simulated outpatient pharmacy

  2019cites this paper
• Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study

  2019cites this paper
• Photo-oxidative degradation of doxorubicin with siloxane MOFs by exposure to daylight

  2019cites this paper
• Safe handling of monoclonal antibodies: Too large to be hazardous?

  2018cites this paper
• A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs

  2017cites this paper
• Surveillance urinaire des professionnels de la santé exposés aux antinéoplasiques dans le cadre de leur travail : revue de la littérature de 2010 à 2015

  2016cites this paper
• Benefits of Wipe Sampling: Evaluation of Long-Term 5-Fluorouracil and Platinum Monitoring Data

  2016cites this paper
• Estudio observacional del circuito del medicamento oncológico hospitalario

  2015cites this paper